Case Report: Bullous erythema multiforme induced by omalizumab - Top-Institutions - MDSpire

Case Study: Omalizumab-Induced Bullous Erythema Multiforme

  • By

  • Zenan Tang

  • Yan Zhao

  • July 17, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Dermatology
    • Immunodermatology

  • #2

    University of Pennsylvania, Perelman School of Medicine
    University of Pennsylvania, Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Dermatology
    • Autoimmune Blistering Disorders

Original Source(s)

Case Report: Bullous erythema multiforme induced by omalizumab

  • by Zenan Tang, Yan Zhao

  • July 17, 2026

Related Content

Case Report: Erythema gyratum repens associated with adenomyosis and endometriosis: an immunological twist?

Proteomics and transcriptomics reveal molecular subtypes and biomarkers of advanced cutaneous T-cell lymphoma

Commentary: Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence